Table 1.

Infectious profile in colombian patients with SpAs

AllASPsAUnd SpAp-value
N=621N=340N=222N=59
N%N%N%N%
Latent TB251/39863,1156/24463,976/12660,319/2867,90,009
Positive TST before immunotherapy175/3984498/24440,264/12650,813/2846,40,64
TST conversion during immunotherapy76/39819,159/24424,213/12610,34/2814,3<.0001
Active TB182,9123,541,823,40,03
Latent TB conversion to active TB71,161,810,400,04
Active TB during immunotherapy111,8102,910,400,008
Hepatitis B11/4002,84/2411,76/1284,71/313,20,32
Hepatitis C2/4000,52/2410,80/1280/310,61
VDRL test2/2850,71/1670,61/941,10/240,38
HIV3/3300,92/19710/1111/224,50,14
  • Ankylosing spondylitis (AS), psoriatic arthritis (PsA), undifferentiated spondyloarthritis (Und SpA), tuberculin skin test (TST).